In the realm of chemical research, certain compounds emerge as exceptionally valuable due to their versatility and role in creating more complex molecular structures. 3-Bromo-4-methylpyridine, identified by its CAS number 3430-22-6, is one such compound. This pyridine derivative is recognized as a crucial intermediate in various chemical synthesis processes, particularly within the pharmaceutical industry.

The fundamental importance of 3-Bromo-4-methylpyridine lies in its chemical structure, which features a pyridine ring functionalized with a bromine atom and a methyl group. This specific arrangement makes it an excellent starting material for a wide array of organic reactions, including those that form new carbon-carbon bonds or introduce other functional groups. These reactions are essential for building the complex molecular frameworks found in many modern drugs and advanced materials.

A significant application of this intermediate is in the synthesis of pharmaceutical compounds. It is particularly noted for its use in the production of proton pump inhibitors, a class of drugs widely used to treat gastrointestinal issues. Beyond this, its utility as a fine chemical building block extends to the research and development of other therapeutic agents, such as those targeting inflammatory pathways or acting as enzyme inhibitors. The efficiency of 3-Bromo-4-methylpyridine synthesis directly impacts the feasibility and cost-effectiveness of these pharmaceutical endeavors.

For researchers and chemical manufacturers, understanding the properties and safe handling of 3-Bromo-4-methylpyridine is crucial. Information regarding its physical state (a clear liquid), solubility, and safety classifications (e.g., irritant) is readily available from suppliers like NINGBO INNO PHARMCHEM CO.,LTD. Ensuring access to high-purity CAS 3430-22-6 and adhering to proper safety protocols are key to successful outcomes in chemical research. As the demand for innovative pharmaceuticals and specialty chemicals continues to grow, the role of intermediates like 3-Bromo-4-methylpyridine will remain vital.